May 19, 2014 10:24 AM

Proteon Therapeutics wins $45 million financing round

A biotechnology firm founded in Kansas City 2001 will proceed with clinical trials of its signature drug, thanks to $45 million in equity financing. Proteon Therapeutics is working to a solve a common problem for patients on kidney dialysis.

Related content